Open Positions: Senior Associate Scientist, In-Vivo Biology
Arvinas is a clinical-stage biopharmaceutical company leading the way in targeted protein degradation therapeutics. Arvinas is the first company to focus solely on protein degradation and its platform technology is the most advanced in the field. Since its founding in 2013, Arvinas’ PROTAC® Discovery Engine has been driving the most significant breakthroughs in the industry. Arvinas’ pipeline encompasses a range of validated and undruggable targets in oncology, immuno-oncology, and neuroscience. This includes two clinical-stage programs: ARV-110, which is being developed as a potential treatment for men with late-line metastatic castrate-resistant prostate cancer, and ARV-471, which is being developed as a potential treatment for patients with breast cancer.
#TeamArvinas is made up of more than 200 passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and purpose – to improve the well-being of patients and families impacted by the devastating diseases Arvinas is working to treat. It’s an exciting time to be in drug development and it’s an exciting time to be at Arvinas. But don’t just take our word for it – here’s what Arvinas employees are saying. For more information, please visit www.arvinas.com.
Arvinas has an outstanding opportunity for an experienced, in-vivo scientist with excellent communication skills. The selected candidate will be willing to work flexible hours. S/he will be a scientist who is interested in drug administration, collection of samples and establishing xenograft tumor models to help develop novel, targeted therapeutics that address the underlying genetic drivers of cancer immunologic and neurologic disorders.
This position reports to the Director of In-Vivo Studies and will be located at our headquarters in New Haven, CT.
Key responsibilities of this role include, but are not limited to:
- Dosing using a variety of routes (PO, IV, IP, SC) in rodents
- Measurement of tumor burden and graphical representation of the emerging data
- Adherence to IACUC protocols and maintenance of accurate records
- Experience in experimental design and execution
- Organized, goal-oriented and timeline-conscious
- Required: ability to dose by oral gavage and/or intravenous tail vein
- Extensive necropsy skills (preferably brain, lymph node and tumor tissue) are a plus
- Preferred experience in developing tumor xenograft models
- BS/MS preferred or comparable experience (8-10) years of Pharma/Biotech drug discovery experience
Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more. To learn more about Arvinas, please visit www.arvinas.com
Arvinas is an Equal Opportunity employer